Published in PLoS One on February 17, 2012
miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet (2012) 2.89
Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal (2014) 2.42
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions. J Hematol Oncol (2014) 1.39
MicroRNA-34a: a potential therapeutic target in human cancer. Cell Death Dis (2014) 1.32
Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med (2013) 1.30
Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin Exp Nephrol (2013) 1.25
Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci (2012) 1.23
A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J (2013) 1.18
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov (2016) 1.03
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer (2013) 0.99
microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition. Oncol Lett (2014) 0.98
The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms. Clin Exp Metastasis (2013) 0.97
Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K/Akt signal. Mol Biol Cell (2014) 0.95
Regulation of angiogenesis by hypoxia: the role of microRNA. Cell Mol Biol Lett (2012) 0.94
HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal (2013) 0.92
Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One (2012) 0.91
HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid Redox Signal (2013) 0.87
Epithelial-mesenchymal transition: An emerging target in tissue fibrosis. Exp Biol Med (Maywood) (2015) 0.86
miR-34a expression, epigenetic regulation, and function in human placental diseases. Epigenetics (2013) 0.86
The Effect of Hypoxia on Mesenchymal Stem Cell Biology. Adv Pharm Bull (2015) 0.85
Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells. J Biol Chem (2015) 0.85
Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma. Oncol Lett (2014) 0.85
The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. Oncotarget (2014) 0.84
Gastric cancer cell growth and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT. Oncol Lett (2014) 0.84
MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway. Mol Med Rep (2015) 0.83
OxymiRs in cutaneous development, wound repair and regeneration. Semin Cell Dev Biol (2012) 0.83
Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAs. Chin Med J (Engl) (2016) 0.82
MicroRNA-769-3p down-regulates NDRG1 and enhances apoptosis in MCF-7 cells during reoxygenation. Sci Rep (2014) 0.81
miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo. Oncotarget (2015) 0.80
Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition. Stem Cells Int (2016) 0.80
Notch signal integration in the vasculature during remodeling. Vascul Pharmacol (2014) 0.80
Notch in fibrosis and as a target of anti-fibrotic therapy. Pharmacol Res (2016) 0.79
Detrimental effects of Notch1 signaling activated by cadmium in renal proximal tubular epithelial cells. Cell Death Dis (2014) 0.78
MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Oncotarget (2015) 0.78
Dichotomy effects of Akt signaling in breast cancer. Mol Cancer (2012) 0.78
Tg737 signaling is required for hypoxia-enhanced invasion and migration of hepatoma cells. J Exp Clin Cancer Res (2012) 0.78
Hypoxic regulation of the noncoding genome and NEAT1. Brief Funct Genomics (2015) 0.77
miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells. Immunogenetics (2013) 0.76
Epithelium-Intrinsic MicroRNAs Contribute to Mucosal Immune Homeostasis by Promoting M-Cell Maturation. PLoS One (2016) 0.76
Emergence of miR-34a in radiation therapy. Crit Rev Oncol Hematol (2016) 0.75
Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner. PLoS One (2017) 0.75
Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex. Nanomedicine (2016) 0.75
MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3. Int J Mol Sci (2015) 0.75
Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion. Oncotarget (2017) 0.75
MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling. Oncol Lett (2017) 0.75
Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma. J Cancer (2017) 0.75
Alternative mechanisms of miR-34a regulation in cancer. Cell Death Dis (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell (2003) 14.07
Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol (2006) 13.12
Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol (2009) 11.50
Signalling downstream of activated mammalian Notch. Nature (1995) 11.08
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature (2006) 8.28
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res (2008) 7.45
A microRNA signature of hypoxia. Mol Cell Biol (2006) 7.24
Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell (2005) 7.07
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med (2011) 6.85
The miR-34 family in cancer and apoptosis. Cell Death Differ (2009) 5.92
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A (2007) 5.50
Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol (2004) 5.43
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A (2007) 4.92
Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med (2005) 4.92
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene (2007) 4.90
Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev (2003) 4.89
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest (2007) 4.80
Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J (2004) 4.77
Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer (2008) 4.50
Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol (2005) 4.35
MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One (2006) 4.29
Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet (2010) 4.01
The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med (2008) 3.76
A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA (2006) 3.71
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H). Curr Biol (1995) 3.46
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res (2005) 3.41
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA (2011) 3.16
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res (2006) 3.05
Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int (2009) 2.86
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett (2008) 2.81
Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol (2010) 2.45
Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest (2010) 2.42
Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol (2003) 2.18
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol (2006) 2.03
miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes (2010) 1.95
Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci U S A (2008) 1.93
Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest (2008) 1.89
Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res (2007) 1.88
E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes (2010) 1.85
Notch signaling: the demise of elegant simplicity. Curr Opin Genet Dev (2004) 1.79
Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest (2008) 1.76
Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens (2009) 1.59
Hypoxia activates the notch signaling pathway in cells of the intervertebral disc: implications in degenerative disc disease. Arthritis Rheum (2011) 1.58
Regulation of microRNA expression: the hypoxic component. Cell Cycle (2007) 1.49
Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle (2008) 1.49
The microRNA-200 family regulates epithelial to mesenchymal transition. ScientificWorldJournal (2008) 1.44
Versican mediates mesenchymal-epithelial transition. Mol Biol Cell (2006) 1.34
High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett (2010) 1.34
Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol (2002) 1.34
Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. J Biol Chem (2004) 1.31
Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int (2010) 1.27
miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS One (2010) 1.23
Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res (1995) 1.10
Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis. Ann N Y Acad Sci (2009) 1.04
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Oncol Rep (2005) 0.93
URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin. Biochem Biophys Res Commun (2009) 0.82
Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression. J Transl Med (2011) 0.82
Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci U S A (2004) 4.13
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer (2008) 4.09
MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet (2010) 3.12
Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int (2009) 2.86
HMGB1 promotes drug resistance in osteosarcoma. Cancer Res (2011) 2.82
AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137. Med Phys (2009) 2.62
Net primary production of Chinese croplands from 1950 to 1999. Ecol Appl (2007) 2.61
Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies. BMC Genomics (2005) 2.34
MicroRNA profiling of human gastric cancer. Mol Med Rep (2011) 2.26
Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS Pathog (2008) 2.09
Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency. Int J Cancer (2008) 2.09
Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect Immun (2004) 1.70
Evolutionary history of lagomorphs in response to global environmental change. PLoS One (2013) 1.68
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol (2010) 1.62
A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Crit Care Med (2008) 1.62
Twist overexpression promoted epithelial-to-mesenchymal transition of human peritoneal mesothelial cells under high glucose. Nephrol Dial Transplant (2012) 1.57
Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis. Arch Med Res (2011) 1.55
In vivo cancer diagnosis with optical spectroscopy and acoustically induced blood stasis using a murine MCa35 model. Med Phys (2006) 1.54
Human mitochondrial Mrs2 protein promotes multidrug resistance in gastric cancer cells by regulating p27, cyclin D1 expression and cytochrome C release. Cancer Biol Ther (2009) 1.50
Luffa echinata Roxb. induces human colon cancer cell (HT-29) death by triggering the mitochondrial apoptosis pathway. Molecules (2012) 1.48
RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties. Heart Rhythm (2012) 1.48
Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci (2007) 1.48
Soybean susceptibility to manufactured nanomaterials with evidence for food quality and soil fertility interruption. Proc Natl Acad Sci U S A (2012) 1.47
Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein. Autophagy (2011) 1.47
Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol (2006) 1.44
PCB association with model phospholipid bilayers. Environ Sci Technol (2008) 1.42
Experimental and clinical observations of 99mTc-MIBI uptake correlate with P-glycoprotein expression in lung cancer. Nucl Med Commun (2007) 1.41
Transcriptional profiling identifies a role for BrlA in the response to nitrogen depletion and for StuA in the regulation of secondary metabolite clusters in Aspergillus fumigatus. Eukaryot Cell (2008) 1.41
Vivo motion and force measurement of surgical needle intervention during prostate brachytherapy. Med Phys (2006) 1.36
Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol (2007) 1.35
The early stage of bacterial genome-reductive evolution in the host. PLoS Pathog (2010) 1.35
Synchronous incidental gastrointestinal stromal and epithelial malignant tumors. World J Gastroenterol (2009) 1.35
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis (2012) 1.32
Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials (2008) 1.29
Nanomaterials and the environment: a review for the biennium 2008-2010. J Hazard Mater (2010) 1.28
Towards consensus practices to qualify safety biomarkers for use in early drug development. Nat Biotechnol (2010) 1.25
Single-layered ultrasmall nanoplates of MoS2 embedded in carbon nanofibers with excellent electrochemical performance for lithium and sodium storage. Angew Chem Int Ed Engl (2014) 1.24
Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer. Cancer Res (2013) 1.21
Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One (2012) 1.20
RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci (2011) 1.19
Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy (2012) 1.19
Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies (review). Oncol Rep (2012) 1.16
Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res (2007) 1.14
Self-Assembling Calix[4]arene [2]Catenanes. Preorganization, Conformation, Selectivity, and Efficiency. J Org Chem (1999) 1.14
Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer Res (2007) 1.14
Genetic diversity and geographic differentiation in endangered Ammopiptanthus (Leguminosae) populations in desert regions of northwest China as revealed by ISSR analysis. Ann Bot (2005) 1.13
Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proc Natl Acad Sci U S A (2013) 1.12
Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int (2012) 1.12
Direct observation of lithium staging in partially delithiated LiFePO4 at atomic resolution. J Am Chem Soc (2011) 1.12
Changes in the level of serum liver enzymes after laparoscopic surgery. World J Gastroenterol (2003) 1.12
DAMP-mediated autophagy contributes to drug resistance. Autophagy (2011) 1.10
LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J Cell Biochem (2008) 1.09
Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer (2010) 1.08
Identification of nuclear import mechanisms for the neuronal Cdk5 activator. J Biol Chem (2006) 1.08
RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci (2007) 1.07
Prospective Analysis of 8589 Patients With Colonic Cancer: Can We Conclude That Anastomotic Leak Is a Prognostic Factor? Ann Surg (2016) 1.07
MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer (2013) 1.07
Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer (2008) 1.07
Whole-genome sequencing uncovers the genetic basis of chronic mountain sickness in Andean highlanders. Am J Hum Genet (2013) 1.06
Genetic regulation of endotoxin-induced airway disease. Genomics (2004) 1.06
Abnormal neural activities in first-episode, treatment-naïve, short-illness-duration, and treatment-response patients with major depressive disorder: a resting-state fMRI study. J Affect Disord (2011) 1.06
Reg4 protects against acinar cell necrosis in experimental pancreatitis. Gut (2010) 1.06
Genome-wide expression analysis of iron regulation in Burkholderia pseudomallei and Burkholderia mallei using DNA microarrays. FEMS Microbiol Lett (2005) 1.05
Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab (2007) 1.05
Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One (2009) 1.05
Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol (2013) 1.05
The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin Cancer Res (2012) 1.05
miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a. Mol Cancer Res (2013) 1.05
A review of Omics research in acupuncture: the relevance and future prospects for understanding the nature of meridians and acupoints. J Ethnopharmacol (2012) 1.04
The limits of log-ratios. BMC Biotechnol (2004) 1.04
Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling. Eur J Pharmacol (2009) 1.04
Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci (2010) 1.03
Self-supported Li4Ti5O12-C nanotube arrays as high-rate and long-life anode materials for flexible Li-ion batteries. Nano Lett (2014) 1.03
Transplacental and early life exposure to inorganic arsenic affected development and behavior in offspring rats. Arch Toxicol (2009) 1.01
AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression. Diagn Pathol (2014) 1.01
microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review). Int J Oncol (2011) 1.00
The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock (2009) 1.00
Genipin-crosslinked silk fibroin/hydroxybutyl chitosan nanofibrous scaffolds for tissue-engineering application. J Biomed Mater Res A (2010) 0.99
The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression. J Interferon Cytokine Res (2010) 0.99
Malignant mixed müllerian tumor of the fallopian tube: report of two cases and review of literature. Arch Gynecol Obstet (2009) 0.99
2-Ethyl-6-methyl-anilinium 4-methyl-benzene-sulfonate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.99
Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition. Mol Cancer Res (2008) 0.98
Sodium butyrate prevents lethality of severe sepsis in rats. Shock (2007) 0.98
Development of a rabbit corneal equivalent using an acellular corneal matrix of a porcine substrate. Mol Vis (2008) 0.98
HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells. BMB Rep (2011) 0.98
Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2012) 0.97
High mobility group box-1 protein regulate immunosuppression of regulatory T cells through toll-like receptor 4. Cytokine (2011) 0.97
Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways. Mol Immunol (2006) 0.97
Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein. Biochem Cell Biol (2007) 0.97
Fabrication of silk fibroin blended P(LLA-CL) nanofibrous scaffolds for tissue engineering. J Biomed Mater Res A (2010) 0.97
MicroRNA-501 promotes HBV replication by targeting HBXIP. Biochem Biophys Res Commun (2012) 0.96
Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth. Mol Ther (2008) 0.96
Presynaptic defects underlying impaired learning and memory function in lipoprotein lipase-deficient mice. J Neurosci (2009) 0.96
Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+ CD25(high) T cells. PLoS One (2011) 0.96
A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth. Biochem Biophys Res Commun (2013) 0.96